Hedong XIANG, Chuan LIU, Jingbin KE, et al. Correlation of hypocalcemia with poor prognosis of COVID-19 based on COX regression model: an analysis of 2 651 patients[J]. Journal of Third Military Medical University, 2021, 43(8): 722-729.
DOI:
Hedong XIANG, Chuan LIU, Jingbin KE, et al. Correlation of hypocalcemia with poor prognosis of COVID-19 based on COX regression model: an analysis of 2 651 patients[J]. Journal of Third Military Medical University, 2021, 43(8): 722-729. DOI: 10.16016/j.1000-5404.202011151.
Correlation of hypocalcemia with poor prognosis of COVID-19 based on COX regression model: an analysis of 2 651 patients
To investigate whether hypocalcemia is associated with poor prognosis in COVID-19 patients.
Methods
2
A retrospective analysis was performed on 2 651 COVID-19 patients admitted to Wuhan Huoshenshan Hospital from February 4
2020 to April 11
2020. They were divided into low and normal calcium groups according to their serum calcium level lower than 2.11 mmol/L or not. Their basic demographic characteristics
results of laboratory tests
treatment
complications and outcomes were analyzed and compared between the 2 groups. COX regression model was used to analyze whether low calcium is an independent risk factors for poor outcomes in COVID-19 patients.
Results
2
The low calcium group had significantly higher ratios of mechanical ventilation
extracorporeal membrane oxygenation (ECMO) and ICU occupancy (
P
<
0.05); obviously higher incidences of sepsis
shock
hypoproteinemia
respiratory failure
coagulation disorders
acute kidney injury
acute myocardial injury
acute respiratory distress syndrome (ARDS)
and even mortality (
P
<
0.05); and remarkably longer length of hospital stay (
P
<
0.001) when compared with the normal calcium group. The blood calcium level of mild and common
severe
and critical COVID-19 patients was 2.17 (2.11
2.24)
2.13 (2.04
2.21)
and 2.03 (1.89
2.18) mmol/L
respectively
and significant differences were seen among the patients (
P
<
0.05). The calcium level was in a decreasing trend with the severity of COVID-19 (
P
<
0.05). The calcium level was statistically lower in the dead patients than those survival [1.97 (1.87
2.03)
vs
2.17 (2.09
2.23)
P
<
0.001
]
. Multivariate Cox regression analysis indicated that serum calcium concentration
<
2.11 mmol/L was an independent risk factor for poor prognosis of COVID-19 (
HR
=5.695
95%
CI
: 2.363~13.725
P
<
0.001).
Conclusion
2
Low blood calcium level is an independent risk factor for poor prognosis in COVID-19 patients. Correction for hypocalcemia may be an important strategy to improve the prognosis of COVID-19 patients.
关键词
Keywords
references
HUANG C, WANG Y, LI X, et al . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J ] . Lancet, 2020, 395(10223): 497-506. DOI: 10.1016/S0140-6736(20)30183-5.
CHEN N, ZHOU M, DONG X, et al . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J ] . Lancet, 2020, 395(10223): 507-513. DOI: 10.1016/S0140-6736(20)30211-7.
CHEUNGPASITPORN W, THONGPRAYOON C, MAO M A, et al . Impact of admission serum calcium levels on mortality in hospita lized patients[J ] . Endocr Res, 2018, 43(2): 116-123. DOI: 10.1080/07435800.2018.1433200.
MILLET J K, WHITTAKER G R. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells[J]. Virology, 2018, 517: 3-8. DOI: 10.1016/j.virol.2017.12.015.
[WHO. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance[EB/OL ] . [2020-09-25 ] . https://apps.who.int/iris/handle/10665/330854 https://apps.who.int/iris/handle/10665/330854 .
LI X, BAI W F, ZHOU H B. Treatment strategy of COVID-19[J]. Baotou Med College J, 2020, 36 (3) : 118-123. DOI: 10.16833/j.cnki.jbmc.2020.03.043.j.carol carroll nki JBMC. 2020.03.043.
JHA V, ARICI M, COLLINS A J, et al . Understanding kidney care needs and implementation strategies in low-and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference[J ] . Kidney Int, 2016, 90(6): 1164-1174. DOI: 10.1016/j.kint.2016.09.009.
LALA A, JOHNSON K W, JANUZZI J L, et al . Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection[J ] . J Am Coll Cardiol, 2020, 76(5): 533-546. DOI: 10.1016/j.jacc.2020.06.007.
FORCE A D T, RANIERI V M, RUBENFELD G D, et al . Acute respiratory distress syndrome: the Berlin Definition[J ] . JAMA, 2012, 307(23): 2526-2533. DOI: 10.1001/jama.2012.5669.
BILINSKI A, EMANUEL E J. COVID-19 and excess all-cause mortality in the US and 18 comparison countries[J]. JAMA, 2020, 324(20): 2100-2102. DOI: 10.1001/jama.2020.20717.
BUDHATHOKI P, SHRESTHA D B, RAWAL E, et al . Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis[J ] . SN Compr Clin Med, 2020: 1-21. DOI: 10.1007/s42399-020-00515-6.
SCHUTTE A E, HARRISON D G. Immunity, inflammation and the vasculature in the COVID-19 era[J]. J Hypertens, 2020, 38(9): 1701-1702. DOI: 10.1097/HJH.0000000 000002525.
DE LA RICA R, BORGES M, GONZALEZ-FREIRE M. COVID-19: in the eye of the cytokine storm[J]. Front Immunol, 2020, 11: 558898. DOI: 10.3389/fimmu.2020.558898.
JAFARZADEH A, CHAUHAN P, SAHA B, et al . Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions[J ] . Life Sci, 2020, 257: 118102. DOI: 10.1016/j.lfs.2020.118102.
YOUNAN P, IAMPIETRO M, NISHIDA A, et al . Ebola virus binding to Tim-1 on T lymphocytes induces a cytokine storm[J ] . mBio, 2017, 8(5): 2586. DOI: 10.1128/mBio.00845-17.
HUSSAIN F S, ELDEEB M A, BLACKMORE D, et al . Guillain Barre syndrome and COVID-19: Possible role of the cytokine storm[J ] . Autoimmun Rev, 2020, 19(12): 102681. DOI: 10.1016/j.autrev.2020.102681.
ASBAGHI O, SADEGHIAN M, MOZAFFARI-KHOSRAVI H, et al . The effect of vitamin d-calcium co-supplementation on inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials[J ] . Cytokine, 2020, 129: 155050. DOI: 10.1016/j.cyto.2020.155050.
KLEIN G L. The role of calcium in inflammation-associated bone resorption[J]. Biomolecules, 2018, 8(3): 69. DOI: 10.3390/biom8030069.
DI FILIPPO L, FORMENTI A M, DOGA M, et al . Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients[J ] . Endocrine, 2021, 71(1): 9-13. DOI: 10.1007/s12020-020-02541-9.
BOOTH C M, MATUKAS L M, TOMLINSON G A, et al . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area[J ] . JAMA, 2003, 289(21): 2801-2809. DOI: 10.1001/jama.289.21.JOC30885.
LIU J, HUANG Q, YANG M, et al . Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism[J ] . J Int Med Res, 2020, 48(1): 300060519897505. DOI: 10.1177/0300060519897505.
AMIRJAMSHIDI A. Hypocalcemia as a prognostic factor in mortality and morbidity in moderate and severe traumatic brain injury[J]. Asian J Neurosurg, 2015, 10(3): 138.
SUN X, ZHANG X, LU, Y, et al . Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism[J ] . Sci Rep, 2018, 8(1): 7743. DOI: 10.1038/s41598-018-26142-9.
CHISTHI M M, NAIR R S, KUTTANCHETTIYAR K G, et al . Mechanisms behind post-thyroidectomy hypocalcemia: interplay of calcitonin, parathormone, and albumin—a prospective study[J ] . J Invest Surg, 2017, 30(4): 217-225. DOI: 10.1080/08941939.2016.1235238.
A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR+/HER2- early breast cancer patients
Immunosuppressive microenvironment of TGIF1-overexpressing gastric cancers and its clinical significance
Related Author
陈黎黎
江黎珠
胡国华
陈鸿雁
WU Zhenzhen
CAO Tingyong
FENG Youfan
ZHAO Li
Related Institution
The First Clinical Medical College, Lanzhou University
Department of Hematology, the Second Hospital & Clinical Medical School, Lanzhou University
Department of Hematology, Gansu Provincial Hospital
Gansu Provincial Clinical Medical Research Center for Molecular Diagnosis and Treatment of Hematological Diseases, the First Hospital, Lanzhou University
The Laboratory Center, the First Hospital, Lanzhou University